CM Management’s ClearPoint Neuro CLPT Stock Holding History

CM Management’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.36M	Buy	150,000 +70,000	+88%	+$884K	1.14%	33
2025 Q4	$1.09M	Hold	80,000	–	–	0.92%	36
2025 Q3	$1.74M	Sell	80,000 -120,000	-60%	-$1.41M	1.45%	24
2025 Q2	$2.39M	Buy	200,000 +25,000	+14%	+$315K	2.17%	13
2025 Q1	$2.08M	Sell	175,000 -115,000	-40%	-$1.79M	2.09%	20
2024 Q4	$4.46M	Sell	290,000 -10,000	-3%	-$130K	3.98%	4
2024 Q3	$3.36M	Sell	300,000 -75,000	-20%	-$718K	2.68%	10
2024 Q2	$2.02M	Hold	375,000	–	–	1.85%	20
2024 Q1	$2.55M	Buy	375,000 +175,000	+88%	+$1.22M	2.14%	15
2023 Q4	$1.36M	Hold	200,000	–	–	1.09%	34
2023 Q3	$1M	Buy	200,000 +20,000	+11%	+$119K	1.06%	33
2023 Q2	$1.3M	Buy	180,000 +5,000	+3%	+$42.5K	1.27%	25
2023 Q1	$1.48M	Buy	175,000 +23,190	+15%	+$203K	1.75%	18
2022 Q4	$1.29M	Buy	151,810 +31,810	+27%	+$302K	1.54%	22
2022 Q3	$1.24M	Sell	120,000 -5,000	-4%	-$65.9K	1.39%	27
2022 Q2	$1.63M	Buy	125,000 +15,000	+14%	+$153K	1.74%	21
2022 Q1	$1.15M	Buy	110,000 +40,000	+57%	+$364K	0.96%	34
2021 Q4	$785K	Buy	+70,000	New	+$1.05M	0.59%	57
2021 Q1	–	Sell	-210,000	Closed	-$3.34M	–	87
2020 Q4	$3.34M	Buy	+210,000	New	+$1.88M	3.09%	7

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

CM Management's CLPT Position: Q1 2026 in Review

CM Management increased its ClearPoint Neuro (CLPT) stake by 88% in Q1 2026, buying an estimated $884K and bringing the position to 150,000 shares worth $1.36M. The position accounts for 1.14% of the portfolio, ranked #33.

CM Management first reported a position in CLPT in Q4 2020 and has held it in 19 quarters since. The position peaked at $4.46M in Q4 2024. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

CM Management held 150,000 shares of ClearPoint Neuro worth $1.36M as of Q1 2026.
CM Management bought 70,000 ClearPoint Neuro shares in Q1 2026, an estimated $884K.
ClearPoint Neuro made up 1.14% of CM Management's portfolio in Q1 2026, its #33 holding.
CM Management first reported a position in ClearPoint Neuro in Q4 2020 and has held it in 19 quarters since.
CM Management's ClearPoint Neuro position peaked at $4.46M in Q4 2024.
118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on CM Management's 13F filing for Q1 2026, filed 8 May 2026.